Neurology
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study.
To compare efficacy and safety of gabapentin (GPT) versus placebo for prophylaxis of chronic daily headache (CDH) (headache at least 15 days/month of greater than 4 hours duration over preceding 6 months). ⋯ Gabapentin represents a therapeutic option for chronic daily headache.